Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REPLIGEN CORP | 89,062 | reported | 02 Mar 2026 | tx 241+1,713,991−1,060,256 |
| BIOLIFE SOLUTIONS INC | 15,046 | reported | 24 Feb 2026 | tx 2+15,046 |
| 908 Devices Inc. | 6,516 | reported | 12 Jun 2025 | tx 22+127,173−30,085 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | TAX_WITHHOLDING | REPLIGEN CORP | 9,897 | 124.97 USD | |
| 24 Feb 2026 | GRANT_AWARD | BIOLIFE SOLUTIONS INC | 8,170 | — | |
| 04 Dec 2025 | OTHER | REPLIGEN CORP | 2,000 | — | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 1,784 | 151.01 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 2,100 | 152.17 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 2,923 | 153.14 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 2,500 | 154.32 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 3,000 | 155.45 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 5,737 | 156.22 USD | |
| 13 Nov 2025 | SALE | REPLIGEN CORP | 1,956 | 157.11 USD | |
| 13 Nov 2025 | EXERCISE | REPLIGEN CORP | 2,952 | 33.87 USD | |
| 13 Nov 2025 | EXERCISE | REPLIGEN CORP | 2,952 | 0.00 USD | deriv |
| 12 Nov 2025 | EXERCISE | REPLIGEN CORP | 25,000 | 33.87 USD | |
| 12 Nov 2025 | SALE | REPLIGEN CORP | 3,741 | 154.92 USD | |
| 12 Nov 2025 | SALE | REPLIGEN CORP | 4,740 | 155.85 USD | |
| 12 Nov 2025 | SALE | REPLIGEN CORP | 4,959 | 156.65 USD | |
| 12 Nov 2025 | SALE | REPLIGEN CORP | 464 | 158.51 USD | |
| 12 Nov 2025 | SALE | REPLIGEN CORP | 11,096 | 158.01 USD | |
| 12 Nov 2025 | EXERCISE | REPLIGEN CORP | 25,000 | 0.00 USD | deriv |
| 10 Sept 2025 | SALE | REPLIGEN CORP | 14,882 | 120.19 USD | |
| 10 Sept 2025 | SALE | REPLIGEN CORP | 1,108 | 118.32 USD | |
| 10 Sept 2025 | SALE | REPLIGEN CORP | 96 | 116.34 USD | |
| 10 Sept 2025 | EXERCISE | REPLIGEN CORP | 20,000 | 33.87 USD | |
| 10 Sept 2025 | SALE | REPLIGEN CORP | 2,179 | 122.23 USD | |
| 10 Sept 2025 | SALE | REPLIGEN CORP | 3,262 | 119.64 USD |